Standout Papers

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension 2015 2026 2018 2022 726
  1. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension (2015)
    Nazzareno Galiè, Joan Albert Barberà et al. New England Journal of Medicine
  2. Global incidence and prevalence of idiopathic pulmonary fibrosis (2021)
    Toby M. Maher, Elisabeth Bendstrup et al. Respiratory Research

Citation Impact

57 standout
Sub-graph 1 of 19

Citing Papers

Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
1 intermediate paper

Works of Jonathan Langley being referenced

Global incidence and prevalence of idiopathic pulmonary fibrosis
2021 Standout
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
2019
and 1 more

Author Peers

Author PRM Genetics CCM Last Decade Papers Cites
Jonathan Langley 1332 226 670 17 1.4k
Malcolm F. McGregor 1 57 668
Simon Pirc 1 11 250
Sheila M. Mitchell 2 4 2 31 741
Mary French 2 30 6 89
Paul Vanhaecke 12 595

All Works

Loading papers...

Rankless by CCL
2026